6th Global Pharma SFE Forum

Fleming Europe15 - 16 March 2011, Lisbon, Portugal.
Following the previous five successful SFE conferences, Fleming Europe announced the 6th Pharma SFE Forum. The conventional conference program has been changed to interactive simulation games, case studies discussions, panel and round table sessions. Global Pharma SFE Forum is focused solely on interaction between attendees and expert presenters.

The 2 Focused Streams (Sales, Marketing, CRM, HR, and Training) will consist of Hands-on Case Studies, Workshops, Simulation presentations and Panel discussions.

Case Studies:

  • Detect Recent Trends and Future of Commercial Model
  • Targeting Effectiveness with right Metrics
  • How to Enjoy Change? Challenge of Merger- Acquisition Process
  • Where do you Spend your Promotional Dollar?
  • Using Marketing Simulation to Drive Brand Awareness
  • Innovative Approaches for Creative Marketing and Increasing Sales Trough Diverse, Multi Channel Initiatives
  • Hiring Pharma Sales Reps: Getting the Process Right
  • The Evolving Training Needs of Pharma Sales Force
  • What they "do" they learn: Most Effective Training For Your Sales Force "Simulation Gaming"
  • Achieving a CRM project success
  • Sales Territory Analysis and Optimization
  • Overcoming Restricted Access to Physicians
  • Using Technology to achieve sales force effectiveness
  • Determining Sales Force Size
  • Motivating and Compensating the Sales Force
  • Discovering Proven Methods to Measure the Impact of your Incentives
  • Value your Sales Talents, Cultural Differences

Workshops:

  • Use the opportunity to interact with presenters face-to-face to ask your questions and brainstorm with your peers.

Keynote:

  • Brand-New Holistic Approach of Pharmaceutical Sales Model

Fleming Europe has gathered almost 20 Vice Presidents, Global Heads and Senior Directors. A special part is an evening event to discover Lisbon and enjoy its finest spring hour.

For further information and registration, please visit:
http://www.sfeforum.com

About Fleming Europe conferences
Fleming Europe conferences are events linking business with intelligence. Carefully designed to provide key strategic business information and the best networking opportunities for the participants, our B2B conferences are highly interactive. Number of delegates from specialized industry sectors - brought together by Fleming Europe - become part of a premium community discussing the questions of the day and enjoying the value of a five star event.

Most Popular Now

BioNTech's statement on patent infringement lawsui…

BioNTech SE (Nasdaq: BNTX, "BioNTech") published an official statment: "BioNTech is aware of reports that Moderna has sued Pfizer and BioNTech, alleging that COMIRNATY® i...

Xenpozyme™ (olipudase alfa-rpcp) approved by FDA a…

The U.S. Food and Drug Administration (FDA) has approved Xenpozyme™ (olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of acid...

FDA grants Breakthrough Therapy Designation to Pfi…

Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designat...

Malaria booster vaccine shows durable high efficac…

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of ...

Research reveals widespread use of ineffective COV…

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use...

Efficacy, cash and more will increase booster shot…

The more effective the COVID-19 booster, the more likely people are to get it, according to new Cornell research. And they are more likely to accept the booster shot with...

Strict COVID lockdowns in France improved cardiova…

A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measura...

U.S. clinical trial evaluating antiviral for monke…

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. St...

Stem cell-gene therapy shows promise in ALS safety…

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This...

Novartis invests in early technical development ca…

Novartis today announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will b...

Drug turns cancer gene into "eat me" fla…

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now...

Mucosal antibodies in the airways protect against …

High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three ...